7 news items
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
ZOM
6 May 24
to successfully integrate acquisitions; uncertainty as to our ability to supply products in response to customer demand; uncertainty as to the likelihood
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
ZOM
2 May 24
in response to customer demand; uncertainty as to the likelihood and timing of any required regulatory approvals, and the availability and cost
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
ZOM
1 Apr 24
acquisitions; uncertainty as to our ability to supply products in response to customer demand; uncertainty as to the likelihood and timing of any
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
ZOM
14 Mar 24
acquisitions; uncertainty as to our ability to supply products in response to customer demand; uncertainty as to the likelihood and timing of any
Zomedica Provides NYSE American Listing Update
ZOM
13 Mar 24
; uncertainty as to our ability to supply products in response to customer demand; uncertainty as to the likelihood and timing of any required regulatory
s47cp7rot ao
ZOM
12 Mar 24
acquisitions; uncertainty as to our ability to supply products in response to customer demand; uncertainty as to the likelihood and timing of any
e00g3p6e6slbwuo4o7bxj1glhquplblcbv0e0s5bv06y
ZOM
7 Mar 24
acquisitions; uncertainty as to our ability to supply products in response to customer demand; uncertainty as to the likelihood and timing of any
- Prev
- 1
- Next